Replimune Group Inc. (REPL) News Headlines

▮ More

Date

Headline

1/5/2021 8:25:30 AM Replimune Doses First Patient In Phase 1 Clinical Trial Of RP3

11/20/2020 1:46:37 AM AZN's Covid Jab & Immunosenescence, PFE/BNTX To Seek Emergency Nod For Vaccine, QURE Aces HOPE-B

11/8/2020 9:52:03 AM Week Ahead In Pharma: FDA Decisions, SITC Presentations, 13D SEC Filing

10/22/2020 1:10:48 AM Replimune Prices Public Offering Of 4.69 Mln Shares At $40/Shr

10/15/2020 2:06:24 AM FDA Approves 1st Ebola Drug, CYCN Drops Sickle Cell Disease Drug, VRTX Plunges In After-hours Trade

7/22/2020 7:22:19 AM Replimune Appoints Andrea Pirzkall As Chief Medical Officer, Effective August 31, 2020

6/4/2020 11:32:57 PM CYCN Awaits Sickle Cell Disease Data, TTPH Finalizes Its Suitor, ADMS Faces FDA In Feb

6/3/2020 7:21:39 AM Replimune Q4 Net Loss $15.8 Mln Vs Net Loss $6.7 Mln Last Year

4/24/2019 9:36:27 PM Wedbush Starts Replimune Group Inc. (REPL) At Outperform With $24 Price Target

Older Articles